[CBM] Cambrex Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 1.85 B

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 54.15 Change: 1.45 (2.75%)
Ext. hours: Change: 0 (0%)

chart CBM

Refresh chart

Strongest Trends Summary For CBM

CBM is in the long-term up 176% above S&P in 13 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products consist of active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products. The company serves generic drug companies, and companies that discover and commercialize new small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding31.98 M EPS2.85 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -20.81% Sales Growth - Q/Q-40.05% P/E20.14
P/E To EPS Growth P/S4.8 P/BV7.6 Price/Cash Per Share
Price/Free Cash Flow44.54 ROA13.37% ROE26.34% ROI17.57%
Current Ratio2.2 Quick Ratio1.18 Long Term Debt/Equity0.47 Debt Ratio0.43
Gross Margin35.31% Operating Margin16.19% Net Profit Margin16.66% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.6 M Cash From Investing Activities-12.04 M Cash From Operating Activities35.37 M Gross Profit29.08 M
Net Profit7.99 M Operating Profit12.67 M Total Assets481.08 M Total Current Assets233.17 M
Total Current Liabilities106.17 M Total Debt60 M Total Liabilities236.88 M Total Revenue77.53 M
Technical Data
High 52 week67.4 Low 52 week42.65 Last close67 Last change-0.59%
RSI81.19 Average true range1.57 Beta1.22 Volume174.76 K
Simple moving average 20 days4.97% Simple moving average 50 days12.6% Simple moving average 200 days25.82%
Performance Data
Performance Week3.47% Performance Month5.1% Performance Quart46.29% Performance Half25.82%
Performance Year28.6% Performance Year-to-date39.58% Volatility daily1.48% Volatility weekly3.32%
Volatility monthly6.8% Volatility yearly23.56% Relative Volume145.8% Average Volume386.69 K
New High New Low

News

2019-03-19 09:47:14 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-03-14 08:00:00 | Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan

2019-03-13 15:38:56 | Do You Like Cambrex Corporation NYSE:CBM At This P/E Ratio?

2019-03-12 09:30:01 | Should Value Investors Pick Cambrex Corporation CBM Stock?

2019-02-18 08:03:31 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-02-17 08:20:00 | 3 Top Biotech Stocks to Buy in February

2019-02-15 09:19:51 | CBM Missed Earnings by Over 90%

2019-02-13 15:58:24 | Cambrex Corp CBM Q4 2018 Earnings Conference Call Transcript

2019-02-13 11:25:00 | Why Cambrex Corporation Is Tanking Today

2019-02-13 08:05:01 | Cambrex CBM Surpasses Q4 Earnings Estimates

2019-02-13 07:10:40 | Cambrex: 4Q Earnings Snapshot

2019-02-13 06:40:00 | Cambrex Reports Fourth Quarter and Full Year 2018 Financial Results

2019-02-11 09:24:02 | Cambrex CBM Upgraded to Buy: Here's What You Should Know

2019-02-08 15:47:09 | Cambrex to Announce Fourth Quarter and Full Year 2018 Financial Results on February 13, 2019

2019-02-01 08:01:47 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-01-31 09:30:02 | CBM or ILMN: Which Is the Better Value Stock Right Now?

2019-01-30 08:01:44 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-01-24 08:02:41 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-01-18 09:10:02 | Is Cambrex CBM a Great Value Stock Right Now?

2019-01-16 08:01:49 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-01-15 08:01:42 | See what the IHS Markit Score report has to say about Cambrex Corp.

2019-01-09 09:30:02 | CBM or ALKS: Which Is the Better Value Stock Right Now?

2019-01-08 11:35:40 | Have Insiders Been Selling Cambrex Corporation NYSE:CBM Shares?

2019-01-04 07:35:00 | New Research Coverage Highlights Twenty-First Century Fox, Hill-Rom, Amphenol, Imperva, Maximus, and Cambrex — Consolidated Revenues, Company Growth, and Expectations for 2019

2019-01-02 09:40:00 | Cambrex Completes Acquisition of Avista Pharma Solutions

2018-12-24 08:01:31 | See what the IHS Markit Score report has to say about Cambrex Corp.

2018-12-18 06:49:46 | Hedge Funds Are Crazy About Cambrex Corporation CBM

2018-12-17 07:30:00 | Pharmaceutical ingredient manufacturer plans expansion in High Point

2018-12-13 08:02:42 | See what the IHS Markit Score report has to say about Cambrex Corp.

2018-12-11 10:32:22 | Cambrex Expands Analytical Capabilities at its High Point, NC Site

2018-12-11 08:02:47 | See what the IHS Markit Score report has to say about Cambrex Corp.

2018-12-09 08:59:28 | Interested In Cambrex Corporation NYSE:CBM? Here’s What Its Recent Performance Looks Like

2018-12-08 08:02:38 | See what the IHS Markit Score report has to say about Cambrex Corp.

2018-11-22 08:01:42 | See what the IHS Markit Score report has to say about Cambrex Corp.

2018-11-20 13:02:21 | [$$] Cambrex Buying Avista Pharma Solutions From Ampersand for $252 Million

2018-11-20 06:40:00 | Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network

2018-11-15 08:01:42 | See what the IHS Markit Score report has to say about Cambrex Corp.

2018-11-13 08:01:43 | See what the IHS Markit Score report has to say about Cambrex Corp.

2018-11-09 10:47:01 | Cleantech Building Materials: Amendment of Loan Facility

2018-11-08 17:16:50 | Edited Transcript of CBM earnings conference call or presentation 8-Nov-18 1:30pm GMT

2018-11-08 11:57:27 | Cambrex Corp CBM Q3 2018 Earnings Conference Call Transcript

2018-11-08 10:45:03 | Cambrex CBM Lags Q3 Earnings and Revenue Estimates

2018-11-08 10:14:14 | What Investors Should Know About Cambrex Corporation’s NYSE:CBM Financial Strength

2018-11-08 09:38:13 | Cambrex: 3Q Earnings Snapshot

2018-11-08 06:40:00 | Cambrex Reports Third Quarter 2018 Financial Results

2018-11-05 15:55:00 | Cambrex to Announce Third Quarter 2018 Financial Results on November 8, 2018

2018-11-05 08:52:12 | Cambrex Corporation NYSE:CBM: Should The Future Outlook Worry You?

2018-10-30 17:01:00 | 3 Top Biotech Stocks to Buy Right Now

2018-10-29 13:47:21 | These Fundamentals Make Cambrex Corporation NYSE:CBM Truly Worth Looking At

2018-10-29 08:15:00 | Report: Developing Opportunities within Noah, 3M, Kimberly-Clark, Cambrex, Argan, and Autohome — Future Expectations, Projections Moving into 2018